Dare Bioscience Stock (DARE): Why The Price Surged

  • The stock price of Daré Bioscience Inc (NASDAQ: DARE) increased by 10.52% in the most recent trading session. This is why it happened.

The stock price of Daré Bioscience Inc (NASDAQ: DARE) increased by 10.52% in the most recent trading session. And it also increased by over 37% after-hours. Investors are responding positively to Daré Bioscience announcing that the U.S. Food and Drug Administration (FDA) approved XACIATO [zah-she-AH-toe] (clindamycin phosphate vaginal gel, 2%) (formerly known as DARE-BV1) for the treatment of bacterial vaginosis in females 12 years of age and older.

KEY QUOTES:

“The FDA approval of XACIATO marks a major milestone not only for Daré as a company but, importantly, for the 21 million women impacted by bacterial vaginosis. It is our goal as a company to accelerate the development of differentiated products that can improve outcomes and convenience for women. In the case of XACIATO, this FDA approval comes just three years after we licensed this technology. We are grateful to the FDA for their thoughtful review and the alignment on labeling that gives healthcare providers clear insights into how to use XACIATO in those patient populations in greatest need of a therapeutic option, such as pregnant women and women with recurrent episodes of bacterial vaginosis. We hope that this is the first of many FDA approvals in our efforts to improve the lives of women with treatment options that address some of the most persistent unmet needs.”

— Sabrina Martucci Johnson, President and CEO of Daré Bioscience

“Bacterial vaginosis is not a sexually transmitted infection, but rather an overgrowth of bacteria naturally found in the vagina, which upsets the balance of the natural vaginal microbiome and leads to not only distressing symptoms of odor and discharge but also increases a woman’s risk of preterm birth, infertility, and infections. Today, approximately half of the women treated for bacterial vaginosis experience a recurrence within 12 months of treatment. There is a need for more efficacious and convenient treatment options, particularly products with improved clinical outcomes for not only the newly diagnosed women but, importantly, also for the women who experience multiple episodes of bacterial vaginosis each year. Now that we have achieved this important demonstration of this drug delivery hydrogel platform technology, we are actively exploring the opportunity to leverage it across other unmet needs in women’s health.”

— David Friend, Ph.D., Daré’s Chief Scientific Officer

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.

Baby News

Related Posts

Insights & Outcomes: Tick tendencies and some stretchy cell membranes

Comments Off on Insights & Outcomes: Tick tendencies and some stretchy cell membranes

The Block Bec Dorouos opens up about going through IVF and her journey to motherhood

Comments Off on The Block Bec Dorouos opens up about going through IVF and her journey to motherhood

We Need to Talk About Assisted Reproduction

Comments Off on We Need to Talk About Assisted Reproduction

Sperm are masters of Tetris packing

Comments Off on Sperm are masters of Tetris packing

NSW Government announces new IVF rebate – The Western Weekender

Comments Off on NSW Government announces new IVF rebate – The Western Weekender

Information, Figures and Analytical Insights 2030 – The Bollywood Ticket

Comments Off on Information, Figures and Analytical Insights 2030 – The Bollywood Ticket

Monash IVF Group’s (ASX:MVF) Returns On Capital Not Reflecting Well On The Business

Comments Off on Monash IVF Group’s (ASX:MVF) Returns On Capital Not Reflecting Well On The Business

IVF Market to Witness Massive Growth from 2022 to 2030 : Irvine Scientific, Cook Medical, Auxogyn

Comments Off on IVF Market to Witness Massive Growth from 2022 to 2030 : Irvine Scientific, Cook Medical, Auxogyn

Bride-to-Be Who Died of COVID-19 Incorrectly Believed Vaccine Would Cause Infertility, Fiance Says

Comments Off on Bride-to-Be Who Died of COVID-19 Incorrectly Believed Vaccine Would Cause Infertility, Fiance Says

Bill would require insurers to cover costs of in vitro fertilization

Comments Off on Bill would require insurers to cover costs of in vitro fertilization

Merck Foundation Marks World Art Day by Raising Awareness About Social and Health Issues Through Their Best Film, Song and Fashion Awards 2022

Comments Off on Merck Foundation Marks World Art Day by Raising Awareness About Social and Health Issues Through Their Best Film, Song and Fashion Awards 2022

Low vaccination numbers leading to outbreak

Comments Off on Low vaccination numbers leading to outbreak

Create Account



Log In Your Account